CoChat

Tolbutamide Controls Glucagon Release From Mouse Islets Differently Than Glucose

Open access
Cheng-Xue, Rui, Gómez-Ruiz, Ana, Antoine, Nancy, Noël, Laura A., Chae, Hee-Young, Ravier, Magalie A., Chimienti, Fabrice, Schuit, Frans C., Gilon, Patrick · 2013 · Diabetes
Cited by 89

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

We evaluated the role of ATP-sensitive K+ (KATP) channels, somatostatin, and Zn2+ in the control of glucagon secretion from mouse islets. Switching from 1 to 7 mmol/L glucose inhibited glucagon release. Diazoxide did not reverse the glucagonostatic effect of glucose. Tolbutamide decreased glucagon secretion at 1 mmol/L glucose (G1) but stimulated it at 7 mmol/L glucose (G7). The reduced glucagon secretion produced by high concentrations of tolbutamide or diazoxide, or disruption of KATP channels (Sur1−/− mice) at G1 could be inhibited further by G7. Removal of the somatostatin paracrine influence (Sst−/− mice or pretreatement with pertussis toxin) strongly increased glucagon release, did not prevent the glucagonostatic effect of G7, and unmasked a marked glucagonotropic effect of tolbutamide. Glucose inhibited glucagon release in the absence of functional KATP channels and somatostatin signaling. Knockout of the Zn2+ transporter ZnT8 (ZnT8−/− mice) did not prevent the glucagonostatic effect of glucose. In conclusion, glucose can inhibit glucagon release independently of Zn2+, KATP channels, and somatostatin. Closure of KATP channels controls glucagon secretion by two mechanisms, a direct stimulation of α-cells and an indirect inhibition via somatostatin released from δ-cells. The net effect on glucagon release results from a balance between both effects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db12-0347

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 89

Metadata

Authors
Cheng-Xue, R., Gómez-Ruiz, A., Antoine, N., Noël, L. A., Chae, H.-Y., Ravier, M. A., Chimienti, F., Schuit, F. C., & Gilon, P.
Venue
Diabetes
Published
2013-04-16
Volume
62
Issue
5
Pages
1612-1622
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2097575722
Cited by
89
References
25
FWCI
11.98
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tolbutamide Controls Glucagon Release From Mouse Islets Differently Than Glucose. https://app.cochat.ai/papers/10.2337/db12-0347
The paper
Cheng-Xue, R., Gómez-Ruiz, A., Antoine, N., Noël, L. A., Chae, H.-Y., Ravier, M. A., Chimienti, F., Schuit, F. C., & Gilon, P. (2013). Tolbutamide Controls Glucagon Release From Mouse Islets Differently Than Glucose. Diabetes. https://doi.org/10.2337/db12-0347

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.